Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VPS39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GET4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ARHGEF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLXNB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
OGFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FNDC3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM174B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOSL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAFG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORAI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM214 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on